THERAVANCE INC - COMMON STOCK (THRX)

CUSIP: 88338T104

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
93,178,166
Share change
+4,550,764
Total reported value
$2,775,079,264
Put/Call ratio
75%
Price per share
$29.78
Number of holders
133
Value change
+$130,640,869
Number of buys
86
Number of sells
63

Quarterly Holders Quick Answers

What is CUSIP 88338T104?
CUSIP 88338T104 identifies THRX - THERAVANCE INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - COMMON STOCK (THRX) as of Q2 2014

As of 30 Jun 2014, THERAVANCE INC - COMMON STOCK (THRX) was held by 133 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,178,166 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, Capital World Investors, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, BlackRock Fund Advisors, ALLIANCEBERNSTEIN L.P., CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, and State Street Corp. This page lists 133 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.